Scinovex
articleTop 1% cited

The Lipid Treatment Assessment Project (L-TAP)

Archives of Internal Medicine · 2000 · Vol. 160(4) · pp. 459–459

Abstract

Large proportions of dyslipidemic patients receiving lipid-lowering therapy are not achieving NCEP LDL-C target levels. These findings indicate that more aggressive treatment of dyslipidemia is needed to attain goals established by NCEP guidelines.

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyDyslipidemiaNational Cholesterol Education ProgramMedicineInternal medicineLipid profilePharmacotherapyCoronary heart diseaseRisk assessmentRisk factorCholesterol

MeSH terms

AdultAgedAnticholesteremic AgentsHypolipidemic AgentsCaliforniaCoronary Artery DiseaseFemaleHumansHyperlipidemiasCholesterol, LDLMaleMiddle AgedDrug PrescriptionsRiskRisk Factors
Citations
1,015
FWCI
95.56
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.